The Part B Drug Payment Model has now been stopped, and your victory was possible only because of rheumatologists and rheumatology health professionals who took the time to get involved in advocacy efforts personally. As we prepare to welcome and work with a new Congress and presidential administration, the ACR will continue to advocate for healthcare policies and reforms that ensure safe, effective, affordable and accessible rheumatology care. We appreciate your dedication to your patients and practices, and look forward to continuing this important work to Advance Rheumatology together in 2017.